The global Oncology Companion Diagnostic market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Agilent Technologies, Inc.
Myriad Genetics, Inc.
Thermo Fisher Scientific Inc.
Illumina, Inc.
Abbott
Qiagen N.V.
Invivoscribe, Inc.
ARUP Laboratories
F. Hoffmann-La Roche Ltd.
bioMérieux SA
By Types:
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Immunohistochemistry (IHC)
In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Others
By Applications:
Hospital
Pathology/Diagnostic Laboratory
Academic Medical Center
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Oncology Companion Diagnostic Market Size Analysis from 2023 to 2028
1.5.1 Global Oncology Companion Diagnostic Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Oncology Companion Diagnostic Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Oncology Companion Diagnostic Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Oncology Companion Diagnostic Industry Impact
Chapter 2 Global Oncology Companion Diagnostic Competition by Types, Applications, and Top Regions and Countries
2.1 Global Oncology Companion Diagnostic (Volume and Value) by Type
2.1.1 Global Oncology Companion Diagnostic Consumption and Market Share by Type (2017-2022)
2.1.2 Global Oncology Companion Diagnostic Revenue and Market Share by Type (2017-2022)
2.2 Global Oncology Companion Diagnostic (Volume and Value) by Application
2.2.1 Global Oncology Companion Diagnostic Consumption and Market Share by Application (2017-2022)
2.2.2 Global Oncology Companion Diagnostic Revenue and Market Share by Application (2017-2022)
2.3 Global Oncology Companion Diagnostic (Volume and Value) by Regions
2.3.1 Global Oncology Companion Diagnostic Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Oncology Companion Diagnostic Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Oncology Companion Diagnostic Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Oncology Companion Diagnostic Consumption by Regions (2017-2022)
4.2 North America Oncology Companion Diagnostic Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Oncology Companion Diagnostic Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Oncology Companion Diagnostic Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Oncology Companion Diagnostic Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Oncology Companion Diagnostic Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Oncology Companion Diagnostic Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Oncology Companion Diagnostic Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Oncology Companion Diagnostic Sales, Consumption, Export, Import (2017-2022)
4.10 South America Oncology Companion Diagnostic Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Oncology Companion Diagnostic Market Analysis
5.1 North America Oncology Companion Diagnostic Consumption and Value Analysis
5.1.1 North America Oncology Companion Diagnostic Market Under COVID-19
5.2 North America Oncology Companion Diagnostic Consumption Volume by Types
5.3 North America Oncology Companion Diagnostic Consumption Structure by Application
5.4 North America Oncology Companion Diagnostic Consumption by Top Countries
5.4.1 United States Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
5.4.2 Canada Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
5.4.3 Mexico Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
Chapter 6 East Asia Oncology Companion Diagnostic Market Analysis
6.1 East Asia Oncology Companion Diagnostic Consumption and Value Analysis
6.1.1 East Asia Oncology Companion Diagnostic Market Under COVID-19
6.2 East Asia Oncology Companion Diagnostic Consumption Volume by Types
6.3 East Asia Oncology Companion Diagnostic Consumption Structure by Application
6.4 East Asia Oncology Companion Diagnostic Consumption by Top Countries
6.4.1 China Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
6.4.2 Japan Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
6.4.3 South Korea Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
Chapter 7 Europe Oncology Companion Diagnostic Market Analysis
7.1 Europe Oncology Companion Diagnostic Consumption and Value Analysis
7.1.1 Europe Oncology Companion Diagnostic Market Under COVID-19
7.2 Europe Oncology Companion Diagnostic Consumption Volume by Types
7.3 Europe Oncology Companion Diagnostic Consumption Structure by Application
7.4 Europe Oncology Companion Diagnostic Consumption by Top Countries
7.4.1 Germany Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
7.4.2 UK Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
7.4.3 France Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
7.4.4 Italy Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
7.4.5 Russia Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
7.4.6 Spain Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
7.4.7 Netherlands Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
7.4.8 Switzerland Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
7.4.9 Poland Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
Chapter 8 South Asia Oncology Companion Diagnostic Market Analysis
8.1 South Asia Oncology Companion Diagnostic Consumption and Value Analysis
8.1.1 South Asia Oncology Companion Diagnostic Market Under COVID-19
8.2 South Asia Oncology Companion Diagnostic Consumption Volume by Types
8.3 South Asia Oncology Companion Diagnostic Consumption Structure by Application
8.4 South Asia Oncology Companion Diagnostic Consumption by Top Countries
8.4.1 India Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
8.4.2 Pakistan Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Oncology Companion Diagnostic Market Analysis
9.1 Southeast Asia Oncology Companion Diagnostic Consumption and Value Analysis
9.1.1 Southeast Asia Oncology Companion Diagnostic Market Under COVID-19
9.2 Southeast Asia Oncology Companion Diagnostic Consumption Volume by Types
9.3 Southeast Asia Oncology Companion Diagnostic Consumption Structure by Application
9.4 Southeast Asia Oncology Companion Diagnostic Consumption by Top Countries
9.4.1 Indonesia Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
9.4.2 Thailand Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
9.4.3 Singapore Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
9.4.4 Malaysia Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
9.4.5 Philippines Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
9.4.6 Vietnam Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
9.4.7 Myanmar Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
Chapter 10 Middle East Oncology Companion Diagnostic Market Analysis
10.1 Middle East Oncology Companion Diagnostic Consumption and Value Analysis
10.1.1 Middle East Oncology Companion Diagnostic Market Under COVID-19
10.2 Middle East Oncology Companion Diagnostic Consumption Volume by Types
10.3 Middle East Oncology Companion Diagnostic Consumption Structure by Application
10.4 Middle East Oncology Companion Diagnostic Consumption by Top Countries
10.4.1 Turkey Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
10.4.3 Iran Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
10.4.5 Israel Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
10.4.6 Iraq Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
10.4.7 Qatar Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
10.4.8 Kuwait Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
10.4.9 Oman Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
Chapter 11 Africa Oncology Companion Diagnostic Market Analysis
11.1 Africa Oncology Companion Diagnostic Consumption and Value Analysis
11.1.1 Africa Oncology Companion Diagnostic Market Under COVID-19
11.2 Africa Oncology Companion Diagnostic Consumption Volume by Types
11.3 Africa Oncology Companion Diagnostic Consumption Structure by Application
11.4 Africa Oncology Companion Diagnostic Consumption by Top Countries
11.4.1 Nigeria Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
11.4.2 South Africa Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
11.4.3 Egypt Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
11.4.4 Algeria Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
11.4.5 Morocco Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
Chapter 12 Oceania Oncology Companion Diagnostic Market Analysis
12.1 Oceania Oncology Companion Diagnostic Consumption and Value Analysis
12.2 Oceania Oncology Companion Diagnostic Consumption Volume by Types
12.3 Oceania Oncology Companion Diagnostic Consumption Structure by Application
12.4 Oceania Oncology Companion Diagnostic Consumption by Top Countries
12.4.1 Australia Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
12.4.2 New Zealand Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
Chapter 13 South America Oncology Companion Diagnostic Market Analysis
13.1 South America Oncology Companion Diagnostic Consumption and Value Analysis
13.1.1 South America Oncology Companion Diagnostic Market Under COVID-19
13.2 South America Oncology Companion Diagnostic Consumption Volume by Types
13.3 South America Oncology Companion Diagnostic Consumption Structure by Application
13.4 South America Oncology Companion Diagnostic Consumption Volume by Major Countries
13.4.1 Brazil Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
13.4.2 Argentina Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
13.4.3 Columbia Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
13.4.4 Chile Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
13.4.5 Venezuela Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
13.4.6 Peru Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
13.4.8 Ecuador Oncology Companion Diagnostic Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Oncology Companion Diagnostic Business
14.1 Agilent Technologies, Inc.
14.1.1 Agilent Technologies, Inc. Company Profile
14.1.2 Agilent Technologies, Inc. Oncology Companion Diagnostic Product Specification
14.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Myriad Genetics, Inc.
14.2.1 Myriad Genetics, Inc. Company Profile
14.2.2 Myriad Genetics, Inc. Oncology Companion Diagnostic Product Specification
14.2.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Thermo Fisher Scientific Inc.
14.3.1 Thermo Fisher Scientific Inc. Company Profile
14.3.2 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Specification
14.3.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Illumina, Inc.
14.4.1 Illumina, Inc. Company Profile
14.4.2 Illumina, Inc. Oncology Companion Diagnostic Product Specification
14.4.3 Illumina, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Abbott
14.5.1 Abbott Company Profile
14.5.2 Abbott Oncology Companion Diagnostic Product Specification
14.5.3 Abbott Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Qiagen N.V.
14.6.1 Qiagen N.V. Company Profile
14.6.2 Qiagen N.V. Oncology Companion Diagnostic Product Specification
14.6.3 Qiagen N.V. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Invivoscribe, Inc.
14.7.1 Invivoscribe, Inc. Company Profile
14.7.2 Invivoscribe, Inc. Oncology Companion Diagnostic Product Specification
14.7.3 Invivoscribe, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 ARUP Laboratories
14.8.1 ARUP Laboratories Company Profile
14.8.2 ARUP Laboratories Oncology Companion Diagnostic Product Specification
14.8.3 ARUP Laboratories Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 F. Hoffmann-La Roche Ltd.
14.9.1 F. Hoffmann-La Roche Ltd. Company Profile
14.9.2 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Specification
14.9.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 bioMérieux SA
14.10.1 bioMérieux SA Company Profile
14.10.2 bioMérieux SA Oncology Companion Diagnostic Product Specification
14.10.3 bioMérieux SA Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Oncology Companion Diagnostic Market Forecast (2023-2028)
15.1 Global Oncology Companion Diagnostic Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Oncology Companion Diagnostic Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Oncology Companion Diagnostic Value and Growth Rate Forecast (2023-2028)
15.2 Global Oncology Companion Diagnostic Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Oncology Companion Diagnostic Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Oncology Companion Diagnostic Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Oncology Companion Diagnostic Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Oncology Companion Diagnostic Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Oncology Companion Diagnostic Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Oncology Companion Diagnostic Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Oncology Companion Diagnostic Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Oncology Companion Diagnostic Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Oncology Companion Diagnostic Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Oncology Companion Diagnostic Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Oncology Companion Diagnostic Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Oncology Companion Diagnostic Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Oncology Companion Diagnostic Consumption Forecast by Type (2023-2028)
15.3.2 Global Oncology Companion Diagnostic Revenue Forecast by Type (2023-2028)
15.3.3 Global Oncology Companion Diagnostic Price Forecast by Type (2023-2028)
15.4 Global Oncology Companion Diagnostic Consumption Volume Forecast by Application (2023-2028)
15.5 Oncology Companion Diagnostic Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
The Internal Passenger Status Monitoring System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The PC Diagnostic Tool Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/pl...
The Professional Exhibition Fairs Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...
Executive Summary
Azoth Analytics has released a research report titled "Global Metaverse Market (2024 Edition)" which provides a complete analysis of the Global Metaverse industry in terms of market segmentation By Product (Hardware, Software and Services), By Platform (Desktop, Mobile...
Executive Summary
Azoth Analytics has released a research report titled "Global Classic Car Insurance Market (2024 Edition)" which provides a complete analysis of the Global Classic Car Insurance industry in terms of market segmentation By Vehicle Type (Vintage, and Classic), By Ownersh...
Executive Summary
Azoth Analytics has released a research report titled "Global Gas and Flame Detection Products Market (2024 Edition)" which provides a complete analysis of the Global Gas and Flame Detection Products industry in terms of market segmentation By Type (Fixed Gas Detection...
The professional hand hygiene market offers a comprehensive array of products and solutions meticulously designed to foster effective hand hygiene practices across various professional and institutional environments, including but not limited to healthcare, food service, manufacturing, and hospitali...
The Medical Companion Robots Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactur...
The Professional Retail Pharmacy Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Healthcare Linen Cleaning Industry Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...